Awards & Advancement

Dietz joins Galleon Pharmaceuticals

Thursday, October 27, 2011 11:17 AM

Galleon Pharmaceuticals has named Thomas J. Dietz, Ph.D., chairman. Dietz is chairman and CEO of Waypoint Holdings, a financial-holdings and services company.

More... »

Sequenom names Huang to ophthalmology advisory board

Tuesday, October 25, 2011 02:47 PM

Sequenom, a life sciences company providing innovative genetic analysis solutions, has named Suber Huang, M.D., to its ophthalmology clinical advisory board.

More... »

CertiVox wins 2011 Bully Award

Tuesday, October 25, 2011 01:43 PM

CertiVox has received the Yearling category of the 2011 Bully Award, an honor presented by White Bull Summits to Europe’s leading technology, media and telecommunications companies.

More... »

Garland joins Exelixis

Tuesday, October 25, 2011 12:52 PM

Exelixis has named J. Scott Garland as executive vice president and chief commercial officer. As the company's chief commercial officer, Gardland will oversee the commercial functions of marketing, sales and commercial operations, and collaborate closely with Exelixis' development and manufacturing teams to provide commercial perspective for cabozantinib development efforts across multiple oncology indications.

More... »

NERI receives $45 million grant to support Pediatric Heart Network

Tuesday, October 25, 2011 10:44 AM

New England Research Institutes (NERI) has received a $45 million grant from the National Institutes of Health (NIH) for the continuance of its work on the Pediatric Heart Network (PHN). PHN is a multi-center clinical research network started in 2001, supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, to study congenital and acquired heart diseases that occur in childhood. This grant provides five more years of funding to nine clinical centers and NERI as the data coordinating center, to conduct clinical research studies in children and young adults with heart defects and other heart diseases.

More... »

Metabolomx awarded $1.14 million grant from NCI

Monday, October 24, 2011 01:34 PM

Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, has been awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.

More... »

Sanofi names Meeker CEO of Genzyme

Monday, October 24, 2011 01:18 PM

Sanofi has named David Meeker as chief executive officer of Genzyme, a Sanofi company, effective November 1, 2011. He will report to Christopher A. Viehbacher, chief executive officer of Sanofi, and will join the group management committee. Viehbacher will retain the position of chairman, Genzyme.

More... »

GenoLogics secures $8 million in strategic financing

Friday, October 21, 2011 02:14 PM

GenoLogics has raised $8 million in strategic financing led by new investor Illumina. The financing will be used to accelerate product development for future clinical applications and new desktop sequencing systems, and to expand sales and marketing functions.

More... »

ICON receives contract award from FNIH

Friday, October 21, 2011 01:38 PM

ICON has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study entitled Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects. 

More... »

goBalto secures Series A financing

Thursday, October 20, 2011 11:51 AM

goBalto, developer of new generation web-based clinical research solutions, has raised an undisclosed amount in Series A financing from Silicon Valley-based health technology investors Aberdare Ventures and the West Health Investment Fund. The funds will be used to expand goBalto's corporate activities and to enhance Tracker, its Software-as-a-Service (SaaS) clinical trials platform that was launched in June 2011.

More... »